London, 17 November 2014 – The Global Schizophrenia Therapeutics Market is expected to grow at a CAGR of 2.82 percent from 2014-2018, says research firm TechNavio.
Aging is one of the main causes of central nervous system (CNS) disorders, including schizophrenia, and instances of the disease are increasing worldwide because of rapidly aging global populations.
The latest report from TechNavio focuses on better awareness of schizophrenia among patients and physicians. This awareness will help increase accessibility of schizophrenia drugs and treatments through the projected period.
“Awareness campaigns like World Schizophrenia Day help bring these disorders to the forefront, and increase dialogue surrounding treatment of individuals who live with schizophrenia,” says Faisal Ghaus, Vice President of TechNavio.
“Higher awareness generally translates into more people seeking treatment, which expands the patient pool and will ultimately contribute to the overall growth of the Global Schizophrenia Therapeutics Market.”
The Global Schizophrenia Therapeutics Market is also witnessing an increase in the popularity of long-acting injectable (LAI) antipsychotics because they are capable of attaining higher efficacy in negative and cognitive predominant patients. LAI antipsychotics improve patient compliance, which is important for long-term maintenance of therapeutic drugs. Additionally, they are associated with both reduced hospitalization rates and lower care costs.
Key Information Covered in the Report:
Market segmentation, size and forecast through 2018
Market Growth Drivers:
- Increase in Aging Population
- For a full detailed list, view our report.
Market Challenges:
- Increase in Generic Competition
- For a full detailed list, view our report.
Market Trends:
- Increase in Awareness of Schizophrenia
- For a full detailed list, view our report.
Key Vendors:
- AstraZeneca plc
- Bristol-Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
Other Prominent Vendors:
- Abbott Laboratories
- Chugai Pharmaceutical
- GlaxoSmithKline
- Merck
https://www.technavio.com/%3Cp%3E%C2%A0%3C/p%3E%3Cp%3E%3Ca%20href%3D%22ht…
